These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36969054)

  • 1. Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy.
    Liu B; Wang Q; Mei T; Zheng J; Gao W; Yuan C; Li K; Zhang Y
    Front Oncol; 2023; 13():1106333. PubMed ID: 36969054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
    J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
    Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
    Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy.
    Wang Q; Qiao W; Liu B; Li J; Yuan C; Long J; Hu C; Zang C; Zheng J; Zhang Y
    BMC Gastroenterol; 2022 Mar; 22(1):98. PubMed ID: 35246045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.
    Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
    Ann Surg Oncol; 2015 Mar; 22(3):843-50. PubMed ID: 25269529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection.
    He Z; Chen J; Wang J; Xu L; Zhou Z; Chen M; Zhang Y; Shi M
    Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):76-82. PubMed ID: 32049678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival.
    Sun Y; Zhang H; Long J; Zhang Y; Zheng J; Yuan C
    Front Oncol; 2022; 12():978614. PubMed ID: 36212462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study.
    Li F; Guo Z; Zhang Y; Wang H; Zhang X; Si T; Yu H; Qi L
    Ir J Med Sci; 2015 Dec; 184(4):753-9. PubMed ID: 24972992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
    Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma.
    Xie H; Tian S; Cui L; Yan J; Bai Y; Li X; Wang M; Zhang F; Duan F
    Cancer Manag Res; 2019; 11():4065-4073. PubMed ID: 31118814
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
    Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
    Yoo S; Kim JY; Lim YS; Han S; Choi J
    J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Clonorchis sinensis combined with Hepatitis B virus infection on the prognosis of patients with Hepatocellular Carcinoma following Hepatectomy.
    Li YK; Zhao JF; Yang CL; Zhan GH; Zhang J; Qin SD; Zhou M; Li MJ; Huang JT; Kong FY; Huang H; Chen JH; Xiang BD
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011012. PubMed ID: 36638133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery.
    Zhao YF; Xiong X; Chen K; Tang W; Yang X; Shi ZR
    Front Oncol; 2021; 11():605234. PubMed ID: 33718156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of HBsAg expression in liver tissue on the postoperative recurrence of HCC patients].
    Li QM; Zhou HB; Hu HP; Huang Y; Zhao H; Yang SW
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):347-353. PubMed ID: 35448923
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma.
    Chai B; Wang W; Wang F; Zhou G; Zheng C
    Int J Hyperthermia; 2021; 38(1):1685-1694. PubMed ID: 34843653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CK19 expression with the efficacy of adjuvant transarterial chemoembolization after hepatic resection in hepatocellular carcinoma patients at high risk of recurrence.
    Wu MS; Zhong JH; Chen K; Luo CP; Zhang J; Zhou YJ; Ma Y; Xiang BD
    J Clin Transl Res; 2022 Feb; 8(1):71-79. PubMed ID: 35224238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.